FRISCO, TX–(December 05, 2013) – OxySure® Systems, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), announced today an update from the Medica 2013 Trade Fair in Dusseldorf, Germany, the largest medical device trade show in world, with approximately 130,000 attendees per day over the four day trade fair. (www.medica-tradefair.com) OxySure, co-exhibiting with Medizon B.V., its partner in the Netherlands, experienced a high volume of inquiries regarding its proprietary respiratory solutions. As a result several different countries have begun negotiations on distribution agreements to expand the OxySure brand and products.

“We are extremely pleased with the outcome of our presence at Medica 2013,” stated Julian Ross, CEO of OxySure Systems. “There was a level of excitement from all the visitors to our booth and we have already begun negotiations with over a dozen countries regarding our groundbreaking oxygen from powder solutions. We feel confident that this will enable OxySure to continue expanding its presence on a truly global scale.”

About OxySure Systems, Inc.

OxySure Systems, Inc. (OXYS) is a medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and medical solutions. The company pioneered a safe and easy to use solution to produce medically pure (USP) oxygen from inert powders. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems. OxySure’s products improve access to emergency oxygen that affects the survival, recovery and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other “Immediately Dangerous to Life or Health” (IDLH) environments. www.OxySure.com

Forward-Looking Statements

Statements in this earnings release that are not historical facts are considered to be forward-looking statements. Such statements include, but are not limited to, statements regarding management beliefs and expectations, based upon information available at the time the statements are made, regarding future plans, objectives and performance. All forward-looking statements are subject to risks and uncertainties, many of which are beyond management’s control and actual results and performance may differ significantly from those contained in forward-looking statements. OxySure Systems, Inc. intends any forward-looking statement to be covered by the Litigation Reform Act of 1995 and is including this statement for purposes of said safe harbor provisions. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this news release. OxySure Systems, Inc. undertakes no obligation to update any forward-looking statements to reflect events or circumstances that occur after the date as of which such statements are made. A discussion of certain risks and uncertainties that could cause actual results to differ materially from those contained in forward-looking statements is included in OxySure Systems, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2012.

Investor Contact:

Christian Hansen
Maximum Performance Advisors, Inc.
858-381-4677
christian@maximumperformanceadvisors.com